Revenue

A new FDA approval for an EGFR-mutated lung cancer therapy cuts treatment from hours to minutes, offering new hope and convenience for thousands of patients.

The neuro-focused biotech just acquired a late-stage cancer drug, securing massive funding. Is this a brilliant diversification or a high-stakes gamble?

With FDA approval for a pivotal study, Pulse Biosciences' novel nanosecond ablation technology aims to make atrial fibrillation treatment safer and more precise.

A new partnership aims to build a secure battery supply chain for drones and UAMs, directly responding to US defense restrictions on Chinese tech.

New mid-tier producer Hemlo Mining Corp. celebrates its first gold pour at the historic Hemlo mine, signaling a seamless transition on record gold prices.

Hisense aims to redefine display tech at CES 2026 with its new RGB MiniLED, focusing on eye comfort and challenging rivals in a crowded smart home market.

The automaker adopts advanced IP management software to protect its innovations in EVs and autonomous driving, signaling a critical industry-wide shift.

As the flex office market heats up, niche providers like Urban W Ltd are adopting advanced proptech to streamline operations and redefine luxury service.

A massive order for a new South American copper mine highlights the critical link between advanced mining technology and the world's green energy needs.

ICL Group's deal to acquire acidulant leader Bartek Ingredients signals a major push into the booming functional food market, leveraging unique production.

Molecular Partners readies for a pivotal presentation at the J.P. Morgan conference, showcasing its next-gen DARPin therapeutics for hard-to-treat cancers.

Completing a key mission 5 months early, Rocket Lab deployed novel DiskSat tech, cementing its role in the U.S. military's agile space strategy.

Vision Marine secures critical funds for its electric boat ambitions, but the deal's terms raise questions about shareholder value and its financial health.

Lincoln Gold secures $850k in a high-interest deal with its own chairman, funding Nevada projects but setting the stage for a shareholder vote on control.

The iconic Indian snack giant partners with a global investment firm to accelerate international growth, leveraging deep operational expertise and capital.

Celltrion's SteQeyma autoinjector gets a CHMP nod, enhancing patient care and intensifying competition in Europe's crowded biosimilar market.

Bolstered by positive clinical data and top investors, Kalaris Therapeutics extends its runway to advance TH103, a next-gen treatment for neovascular AMD.

Global agency INVNT appoints its first Chief AI Officer, betting on a unique human-centric leader to navigate the AI revolution in brand storytelling.

Semrush's new app brings live marketing data directly into ChatGPT, promising a new era of efficiency and reshaping the competitive SaaS battleground.

With a bold IPO filing, Boumarang plans to leverage hydrogen power, advanced AI, and maritime drones to challenge giants in the booming autonomous systems market.